Navigating the Tariff Landscape Together
Last Updated: 3/4/2026
We remain committed to keeping you informed as the tariff landscape continues to shift. Our team conducts ongoing reviews and will communicate any relevant changes, ensuring we take proactive steps to minimize potential impacts wherever possible.
What’s Happening Now:
As of February 20, 2026, the Supreme Court determined that the Administration does no have the authority under the International Emergency Economic Powers Act (IEEPA) to impose broad, country-specific tariffs. As a result, there was an executive order put into place instructing agencies to cease collecting IEEPA-related tariffs by February 24, 2026.
- New Global Tariff: In response, the Administration imposed a temporary global tariff of 10% on most imports under Section 122 effective February 24, 2026. This tariff is set to last no more than 150 days unless Congress extends it.
- Tariffs Still in Place: Product-specific tariffs remain active because they were imposed under different legal authorities:
- Section 232 investigation underway on PPE, medical consumables, and devices (including insulin pumps and glucose monitors); comment period closes October 17, with potential tariffs as early as summer 2026.
- Section 232 national security tariffs Section 301 tariffs on specific Chinese imports and other targeted levies
- Continued Legal and Trade Uncertainty: While the Supreme Court declared IEEPA-based tariffs unlawful, it did not prescribe a specific reimbursement mechanism, leaving that task to the Court of International Trade (CIT).
As the Administration evaluates the possibility of further tariff actions, we are closely tracking the evolving landscape so we can keep you updated with the most relevant information.
Our Continued Commitment:
We continue to take proactive steps to minimize the impact of tariffs on your operations:
- Diversifying Our Portfolio: Less than 20% of our product portfolio is sourced from China, and we continue to expand sourcing from other regions.
- Supplier Partnerships: We’re leaning on the strength of our long-standing supplier partnerships to help absorb cost pressures and reduce the impact on you as much as possible.
- Strategic Inventory Planning: We’ve made strategic investments to increase inventory on high-volume items in order to delay the impact of cost increases for as long as possible.
- Advocacy: We are actively working with policymakers to represent EMS needs and we remain an advocate on behalf of EMS in the Section 232 investigations affecting medical devices and equipment.
- Customer Support: For your convenience, we’ve proactively identified and priced a selection of suitable replacement products, ensuring you have readily available alternatives that meet your needs without delay.
- Transparency: We’ll continue to share key updates and, when relevant, your Account Manager will reach out directly about product or pricing changes that affect you.
- Fair Pricing Approach: Our pricing may adjust up or down as tariff conditions change.
Tariff Protected Catalog:
More products were added on 2/27/2026.